The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas

Curr Med Res Opin. 2015 Mar; 31(3):537-45

View abstract

Authors

Macalalad AR, McAuliffe M, Yang H, Kageleiry A, Zhong Y, Wu EQ, Shonukan O, Bonthapally V.